Similar articles

• Pharmacokinetics of tolbutamide: prediction by concentration in saliva.

  Matin SB, Wan SH, Karam JH. Matin SB, et al. Clin Pharmacol Ther. 1974 Dec;16(6):1052-8. doi: 10.1002/cpt19741661052. Clin Pharmacol Ther. 1974. PMID: 4433472 No abstract available.
• Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.

  Andreasen PB, Vesell ES. Andreasen PB, et al. Clin Pharmacol Ther. 1974 Dec;16(6):1059-65. doi: 10.1002/cpt19741661059. Clin Pharmacol Ther. 1974. PMID: 4611464 Clinical Trial. No abstract available.
• [Comparative studies of the oral and intravenous tolbutamide test. II. Determination of glucose, serum-insulin and serum-tolbutamide in normal young subjects].

  Berchtold P, Büber V, Meier V, Felber JP, Keiser G. Berchtold P, et al. Diabetologia. 1971 Apr;7(2):77-81. doi: 10.1007/BF00443885. Diabetologia. 1971. PMID: 5581543 German. No abstract available.
• Interaction between tolbutamide and ketoconazole in healthy subjects.

  Krishnaiah YS, Satyanarayana S, Visweswaram D. Krishnaiah YS, et al. Br J Clin Pharmacol. 1994 Feb;37(2):205-7. doi: 10.1111/j.1365-2125.1994.tb04262.x. Br J Clin Pharmacol. 1994. PMID: 8186066 Free PMC article.
• Basal and tolbutamide-induced plasma somatostatin in healthy subjects and in patients with diabetes and impaired glucose tolerance.

  Segers O, De Vroede M, Michotte Y, Somers G. Segers O, et al. Diabet Med. 1989 Apr;6(3):232-8. doi: 10.1111/j.1464-5491.1989.tb01153.x. Diabet Med. 1989. PMID: 2565779